Salvage Ovarian FANG™ Vaccine + Bevacizumab

Clinical trial NCT01551745 · COMPLETED

Trial details

NCT number: NCT01551745
Sponsor: Gradalis, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage III Ovarian Cancer Stage IV Ovarian Cancer

Start date: 2012-03-01
Primary completion: 2016-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.